OtherCase Studies
Development of a premium Quality Plasma derived IVIg (IQYMUNE®) utilizing the principles of Quality by Design - A worked through case study
Philippe Paolantonacci, Philippe Appourchaux, Béatrice Claudel, Monique Ollivier, Richard Dennett and Laurent Siret
PDA Journal of Pharmaceutical Science and Technology November 2017, pdajpst.2016.007393; DOI: https://doi.org/10.5731/pdajpst.2016.007393
Philippe Paolantonacci
1 Laboratoire Français du Fractionnement et des Biotechnologies;
Philippe Appourchaux
1 Laboratoire Français du Fractionnement et des Biotechnologies;
Béatrice Claudel
1 Laboratoire Français du Fractionnement et des Biotechnologies;
Monique Ollivier
1 Laboratoire Français du Fractionnement et des Biotechnologies;
Richard Dennett
2 Voisin Consulting Life Sciences
Laurent Siret
1 Laboratoire Français du Fractionnement et des Biotechnologies;
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 2
March/April 2025
Development of a premium Quality Plasma derived IVIg (IQYMUNE®) utilizing the principles of Quality by Design - A worked through case study
Philippe Paolantonacci, Philippe Appourchaux, Béatrice Claudel, Monique Ollivier, Richard Dennett, Laurent Siret
PDA Journal of Pharmaceutical Science and Technology Nov 2017, pdajpst.2016.007393; DOI: 10.5731/pdajpst.2016.007393
Development of a premium Quality Plasma derived IVIg (IQYMUNE®) utilizing the principles of Quality by Design - A worked through case study
Philippe Paolantonacci, Philippe Appourchaux, Béatrice Claudel, Monique Ollivier, Richard Dennett, Laurent Siret
PDA Journal of Pharmaceutical Science and Technology Nov 2017, pdajpst.2016.007393; DOI: 10.5731/pdajpst.2016.007393
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.